Why the study?
Does contrast enhanced transesophageal echocardiography improve atrial thrombus detection and reduce embolic adverse events in patients with atrial fibrillation planned for electrical cardioversion?
Does contrast enhanced transesophageal echocardiography improve atrial thrombus detection and reduce embolic adverse events in patients with atrial fibrillation planned for electrical cardioversion?
Contrast-enhanced TEE improves image interpretability and atrial thrombus exclusion in patients with AF undergoing cardioversion, potentially reducing embolic events.
May aid thrombus exclusion on TEE before AF cardioversion; leaves open whether embolic events decline in randomized settings.
In patients with AF planned for CV contrast enhancement renders TEE images more interpretable, facilitates the exclusion of atrial thrombi and may reduce the rate of embolic adverse events.
No takes yet. Share an insight, caveat, or question.
Jung et al. (2013) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: